Form 10-KT/A - Transition reports [Rule 13a-10 or 15d-10]: [Amend]
SEC Accession No. 0000950134-02-002658
Filing Date
2002-03-26
Accepted
2002-03-26 00:00:00
Documents
2
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-K FOR DECEMBER 31, 2001 d94952a1e10-kta.txt 10-KT/A 20624
3 MASTER SERVICES AGREEMENT WITH PPD DEVELOPMENT LLC d94952a1ex10-41.txt EX-10.41 155692
  Complete submission text file 0000950134-02-002658.txt   177964
Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Filer) CIK: 0001018710 (see all company filings)

EIN.: 742704230 | Fiscal Year End: 1231
Type: 10-KT/A | Act: 34 | File No.: 000-21291 | Film No.: 02587050
SIC: 2834 Pharmaceutical Preparations